Search results for "TUNIS"

showing 10 items of 260 documents

BYOTYPES AND RANDOMLY AMPLIFIED POLYMORPHIC DNA (RAPD) PROFILES OF SUBGINGIVAL CANDIDA ALBICANS ISOLATES IN HIV INFECTION

2005

ABSTRACT: A group of subgingival isolates of C. albicans recovered from Italian HIV-positive (HIV+) subjects were characterized both phenotypically and genotypically. Phenotyping of the isolates was carried out by a biotyping method based on the enzyme profiles, carbohydrate assimilation patterns and boric acid resistance of the yeasts. Genotyping was performed through randomly amplified polymorphic DNA (RAPD) analysis. Five biotypes were found among the 29 subgingival C. albicans strains examined. The predominant biotypes were A1R (55.17%), A1S (24.14%), and A2R (13.79%), while the biotypes A11R and A13R were represented by a single isolate each. RAPD profiles identified 15 genotypes among…

AdultMaleSettore MED/07 - Microbiologia E Microbiologia ClinicaAntifungal AgentsAIDS-Related Opportunistic InfectionsGenotypeSettore MED/42 - Igiene Generale E ApplicataDNA FingerprintingRandom Amplified Polymorphic DNA TechniquePhenotypeCandida albicans HIV-positiveBoric AcidsItalySettore MED/28 - Malattie OdontostomatologicheCandidiasis OralDrug Resistance FungalCandida albicansGingival DiseasesHumansFemaleDNA FungalMycological Typing Techniques
researchProduct

Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.

2009

A pterygium is characterized by abnormal fibrovascular corneoconjunctival tissue. A number of investigations have attempted to elucidate this incompletely understood pathology. Since vascular endothelial growth factor (VEGF) and p53 are known to participate in tumor vascularization, our purpose was to study VEGF and p53 expression in active primary and recurrent pterygium from Tunisian patients. To this end, 15 cases of active primary pterygium and five cases of recurrent pterygium from Tunisia were studied by immunohistochemistry. Antibodies raised against VEGF and p53 were used to analyze the distribution and expression of these markers in pterygium and normal human conjunctiva were used …

AdultMaleVascular Endothelial Growth Factor APathologymedicine.medical_specialtyConjunctivaTunisiaAngiogenesisPterygiumPathogenesisNeovascularizationImmunoenzyme Techniqueschemistry.chemical_compoundYoung AdultRecurrenceMedicineHumansCorneal NeovascularizationAgedbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseGenes p53eye diseasesPathophysiologyPterygiumVascular endothelial growth factormedicine.anatomical_structurechemistryImmunohistochemistryFemalesense organsmedicine.symptomTumor Suppressor Protein p53businessConjunctivaPathologie-biologie
researchProduct

Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional s…

2011

Cutaneous leishmaniasis (CL) is endemic in Central Africa, including Cameroon. However, data on its prevalence and co-infection with HIV are scarce. Here we present the results of a large cross-sectional study reporting the prevalence, clinical features and species identification of CL and HIV co-infection in northern Cameroon. A total of 32 466 subjects were clinically screened for CL during a door-to-door survey, followed by parasitological diagnosis in the field laboratory. Amongst the subjects surveyed, 146 (0.4%) were diagnosed with active CL. Seven (4.8%) of these 146 CL patients tested positive for HIV-1 and/or HIV-2. The number of lesions per CL patient ranged from 1 to 20. Three of…

AdultMalemedicine.medical_specialtyAdolescentCross-sectional studyAIDS-Related Opportunistic InfectionsAntiprotozoal AgentsLeishmaniasis CutaneousPolymerase Chain ReactionYoung AdultCutaneous leishmaniasisInternal medicineEpidemiologyHIV SeropositivitymedicineHumansLeishmania majorCameroonYoung adultChildAgedLeishmania majorbiologyAIDS-Related Opportunistic Infectionsbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesInfantGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationVirologyInfectious DiseasesCross-Sectional StudiesChild PreschoolHIV-2CoinfectionHIV-1ParasitologyFemalePublic HealthbusinessTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis

2021

The primary aim of this study was to describe the use of primary anti-infective prophylaxis (AP) in common clinical practice in patients affected by immune thrombocytopenia (ITP) and treated with RTX. Population studied consisted of patients affected by ITP (age ≥ 18 years) who had received at least one dose of RTX from January 2008 to June 2018. Five Italian haematology centres participated in the current study. Data were retrospectively collected: demographic data (age, gender), concomitant comorbidities and previous therapies for ITP, characteristics of AP, the occurrence of infections and their management. The ITP cohort consisted of 67 patients sub-grouped into two categories according…

AdultMalemedicine.medical_specialtyAdolescentPopulationOpportunistic InfectionsPneumocystis pneumoniaYoung Adult03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansPractice Patterns Physicians'educationAgedRetrospective StudiesAged 80 and overPurpura Thrombocytopenic Idiopathiceducation.field_of_studyHematologybusiness.industrySulfamethoxazoleHematologyGeneral MedicineAntibiotic ProphylaxisMiddle Agedmedicine.diseaseTrimethoprimItaly030220 oncology & carcinogenesisConcomitantCohortFemaleRituximabImmune thrombocytopenia . Rituximab . Antimicrobial prophylaxis . InfectionsRituximabbusiness030215 immunologymedicine.drugAnnals of Hematology
researchProduct

Candidal carriage in the oral cavity of human immunodeficiency virus–infected subjects

2002

Abstract Objectives. We sought to assess asymptomatic oral carriage of Candida species and relative density in human immunodeficiency virus-infected (HIV+) subjects, as well as to determine whether yeast carriage is associated with CD4+cell count, HIV-1 RNA quantity, gender, route of HIV transmission, antiretroviral therapy, or smoking. Study Design. A cross-sectional analysis of oral rinses from HIV+ and healthy subjects was undertaken. Oral candidal carriage and relative species were investigated in 42 HIV+ and 41 healthy individuals, all of whom were seen at the Palermo University Department of Oral Sciences, Italy. Data were managed and analyzed by means of the computer software package…

AdultMalemedicine.medical_specialtyColony Count MicrobialAsymptomaticStatistics NonparametricAcquired immunodeficiency syndrome (AIDS)Candidiasis OralInternal medicineHumansMedicineMycological Typing TechniquesSidaCandida albicansGeneral DentistryMycosisCandidaMouthChi-Square DistributionAIDS-Related Opportunistic Infectionsbiologybusiness.industryMiddle AgedViral Loadbiology.organism_classificationmedicine.diseaseCD4 Lymphocyte CountCross-Sectional StudiesCarriageOtorhinolaryngologyOral microbiologyCarrier StateImmunologyHIV-1FemaleSurgeryOral Surgerymedicine.symptombusinessViral loadOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
researchProduct

Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic.

2007

Abstract Objective To assess a panel of risk factors associated to oral candidosis (OC) onset and its chronic maintenance by means of fuzzy logic (FL) approach and statistical traditional methodology (STM); to investigate their casual relationship within a multifactorial framework. Design Case–control study. Setting One hospital-based clinic. Patients Eighty-nine patients with OC infection microbiologically diagnosed and 98 healthy subjects were consecutively recruited. Outcome measurements Anamnestic and clinical evaluations for OC, microbiological assessment (i.e. culture, CFU/mL counting and identification) were performed. The commonest predisposing factors for OC onset and its chronic s…

AdultMalemedicine.medical_specialtyMEDLINEDentistryDiseaseOpportunistic InfectionsXerostomiaSex FactorsFuzzy LogicCandidiasis OralRisk FactorsDiabetes mellitusInternal medicinemedicineHumansOral candidosisRisk factorGeneral DentistryStatisticDenturesAgedAged 80 and overbusiness.industryCase-control studyHealthy subjectsAge FactorsCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseOtorhinolaryngologyCase-Control StudiesAcute DiseaseChronic DiseaseFemalerisk factors associated to oral candidosis (OC) CFU/mL countingbusinessArchives of oral biology
researchProduct

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therap…

2002

In acute lymphoblastic leukemia (ALL), treatment with granulocyte colony stimulating factor (G-CSF) during remission induction shortens granulocytopenia and may decrease morbidity due to infections. However, the optimal timing of G-CSF administration after chemotherapy is not known. In a prospective randomized multi-center study, adult ALL patients were treated with high-dose ARA-C [HDAC, 3 g/m(2) bid (1 g/m(2) bid for T-ALL) days 1-4] and mitoxantrone (MI 10 mg/m(2) days 3-5). They were randomized to receive recombinant human G-CSF (Lenograstim) 263 micro g/day SC starting either from day 12 (Group 1) or day 17 (Group 2). Fifty-five patients (41 male, 14 female) with a median age of 34 yea…

AdultMalemedicine.medical_specialtyNeutropeniaAdolescentHematopoietic growth factormedicine.medical_treatmentOpportunistic InfectionsNeutropeniaGastroenterologyDrug Administration Schedulelaw.inventionRandomized controlled triallawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineHumansProspective StudiesChemotherapyMitoxantroneHematologybusiness.industryCytarabineHematologyGeneral MedicineMiddle AgedPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseHematopoiesisSurgeryGranulocyte colony-stimulating factorLenograstimTreatment OutcomeFemalebusinessmedicine.drugAnnals of Hematology
researchProduct

Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation

2019

The replication kinetics of nonpathogenic anelloviruses belonging to the Alphatorquevirus genus (such as torque teno virus) might reflect the overall state of posttransplant immunosuppression. We analyzed 221 kidney transplant (KT) recipients in whom plasma alphatorquevirus DNA load was quantified by real-time polymerase chain reaction at baseline and regularly through the first 12 posttransplant months. Study outcomes included posttransplant infection and a composite of opportunistic infection and/or de novo malignancy (immunosuppression-related adverse event [iRAE]). Alphatorquevirus DNA loads at month 1 were higher among patients who subsequently developed posttransplant infection (P  = …

AdultMalemedicine.medical_specialtyOpportunistic infectionmedicine.medical_treatment030230 surgeryAnelloviridaeGastroenterologylaw.invention03 medical and health sciences0302 clinical medicinelawInternal medicinemedicineHumansImmunology and AllergyPharmacology (medical)Prospective StudiesAdverse effectPolymerase chain reactionKidney transplantationAgedTransplantationbusiness.industryHazard ratioImmunosuppressionMiddle Agedmedicine.diseaseKidney TransplantationConfidence intervalDNA ViralFemalebusinessViral loadImmunosuppressive AgentsAmerican Journal of Transplantation
researchProduct

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

2007

Patients with neutropenia resulting from chemotherapy for acute myelogenous leukemia or the myelodysplastic syndrome are at high risk for difficult-to-treat and often fatal invasive fungal infections.In this randomized, multicenter study involving evaluators who were unaware of treatment assignments, we compared the efficacy and safety of posaconazole with those of fluconazole or itraconazole as prophylaxis for patients with prolonged neutropenia. Patients received prophylaxis with each cycle of chemotherapy until recovery from neutropenia and complete remission, until occurrence of an invasive fungal infection, or for up to 12 weeks, whichever came first. We compared the incidence of prove…

AdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsNeutropeniaAdolescentItraconazolemedicine.medical_treatmentAntineoplastic AgentsKaplan-Meier EstimateOpportunistic InfectionsNeutropeniaInternal medicineClinical endpointmedicineHumansSingle-Blind MethodFluconazoleAgedAged 80 and overChemotherapyLeukopeniabusiness.industryMyelodysplastic syndromesGeneral MedicineMiddle AgedTriazolesmedicine.diseaseSurgeryLeukemia Myeloid AcuteTreatment OutcomeMycosesMyelodysplastic SyndromesFemaleItraconazolemedicine.symptombusinessFluconazolemedicine.drugNew England Journal of Medicine
researchProduct

Gender differences in human immunodeficiency virus–related oral lesions: An Italian study

2001

Abstract Objective: The purpose of this study was to investigate the relationship between oral lesions and gender, age, CD4+ cell count, human immunodeficiency virus-1 (HIV-1) viral load, antiretroviral therapy, and route of transmission in a group of HIV-infected (HIV+) persons from the Mediterranean region. Study Design: The participants in this study were HIV+ adults who sought dental care between January 1999 and June 1999 in the Department of Oral Medicine (University of Palermo, Italy). Results: One hundred thirty-six HIV+ adults came in for an initial oral examination. Their mean age was 35.2 years (SD ± 7.97), and 33% were women. Their mean CD4+ cell count was 325.3 × 106 /L (SD ± 2…

AdultMalemedicine.medical_specialtyStatistics as TopicHIV InfectionsAntiviral AgentsStatistics NonparametricSex FactorsAcquired immunodeficiency syndrome (AIDS)Candidiasis OralInternal medicineImmunopathologyOral and maxillofacial pathologyEpidemiologyPrevalenceHumansMedicineSidaSicilyGeneral DentistryAnalysis of VarianceChi-Square DistributionAIDS-Related Opportunistic Infectionsbiologybusiness.industryAge FactorsViral Loadmedicine.diseasebiology.organism_classificationCD4 Lymphocyte Countstomatognathic diseasesItalyOtorhinolaryngologyImmunologyHIV-1FemaleSurgeryViral diseaseOral SurgeryMouth DiseasesbusinessViral loadOral medicineOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology
researchProduct